The Alabama Department of Mental Health (ADMH) is responsible for the regulation of Alabama’s public substance abuse services delivery system. ADMH does not operate any substance use disorder programs; however, we contract with community based entities throughout Alabama to offer outpatient and residential services. All state funded providers offer services on a sliding fee scale which is based on income, resulting in low or no cost services to persons with low income.
If an individual is in need of treatment, upon initial contact with a provider, a screening is done to determine eligibility for substance use disorder services. A screening with a score of two or more positive responses indicate high risk and will lead to the assessment. The assessment will determine the appropriate services needed and the recommended level of care.
The screening and assessment begins the process! Find a Provider
Adolescent Services: Adolescent services are offered for youth 13-18 years of age. Providers offer an array of services from outpatient to residential. Adolescent treatment programs can help build a strong foundation for long term recovery. The sooner we can recognize that an adolescent may be using the sooner help can be provided.
Adult Services: Adult services are offered for those 18 and older. Alabama’s treatment providers offer withdrawal management (formerly known as detoxification), residential treatment, intensive outpatient treatment, outpatient treatment and medication assisted treatment. One or more of these services is offered in 59 of Alabama’s 67 counties.
Co-Occurring Services: Co-Occurring treatment programs specialize in treating mental health disorders and substance use disorders concurrently, as better outcomes are achieved when patients receive simultaneous treatment for both disorders. Services are available in Calhoun, Chilton, Cullman, Dale, Jefferson, Lauderdale, Mobile, Montgomery, Morgan, and Shelby counties.
Medication-Assisted Treatment (MAT), including opioid treatment programs (OTPs), combines behavioral therapy and medications to treat substance use disorders. The medications used to treat opioid addiction include buprenorphine (Suboxone, Subutext), methadone, and naltrexone (oral medication or injectable form known as Vivitrol). There are 21 certified OTP programs in Alabama. Some OTP’s offer additional medications (buprenorphine, naltrexone) in addition to methadone. A person may also receive buprenorphine from an office based doctor who has specialized training. Naltrexone may be provide by any doctor. Services are available in Calhoun, Chilton, Colbert, Cullman, Dale, Etowah, Houston, Jackson, Jefferson, Madison, Marion, Mobile, Montgomery, Shelby, Tuscaloosa, and Walker counties.
Women’s Services: Women’s treatment must address the physiological responses to substance use, medical problems and disorders, pregnancy, relationships, trauma, socioeconomic issues, culture, co-occurring disorders, relevant recovery support and continuing care. ADMH receives funding under the Federal Block Grant for pregnant and parenting females. Females eligible to enter must be pregnant; or have care and custody of dependent children; or have lost custody of dependent children and have the potential for family reunification. Children can accompany mom to treatment. Pregnant women have priority admission to ALL certified treatment providers in Alabama and there are NO admission fees for pregnant women and women with dependent children.
Nicole Walden, Director
ADMH has been awarded two grants by the Substance Abuse and Mental Health Services Administration (SAMHSA) to address Alabama’s opioid crisis. The first grant is the State Opioid Response (SOR) grant which was enabled by the 21st Century Cures Act, and is based on Alabama’s opioid death rate and unmet need for opioid addiction treatment. The second grant awarded is the MAT-PDOA (Medication Assisted Treatment-Prescription Drug and Opioid Addiction) grant which will address a targeted capacity expansion. STR is a state wide initiative whereas MAT-PDOA will target citizens in both Jefferson and Walker Counties because they have a significantly higher opioid overdose and opioid overdose death rate per population. Both grants are dedicated to expansion and enhancing access to medication assisted treatment (MAT) services for persons with an opioid use disorder. Some of the goals include: improving public awareness of Alabama's opioid misuse and addiction crisis; increasing available treatment options; increasing the availability of Naloxone in unserved areas of the state; decreasing illicit opioid drug use at six month follow up; and decreasing the use of prescription opioids in a non-prescribed manner at six month follow up.